Risk factors for lethal arrhythmic events in children and adolescents with hypertrophic cardiomyopathy and an implantable defibrillator: An international multicenter study

. 2019 Oct ; 16 (10) : 1462-1467. [epub] 20190423

Jazyk angličtina Země Spojené státy americké Médium print-electronic

Typ dokumentu časopisecké články, multicentrická studie, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid31026510
Odkazy

PubMed 31026510
DOI 10.1016/j.hrthm.2019.04.040
PII: S1547-5271(19)30369-8
Knihovny.cz E-zdroje

BACKGROUND: Predictors of risk of lethal arrhythmic events (LAE) is poorly understood and may differ from adults in children with hypertrophic cardiomyopathy (HCM). OBJECTIVE: The purpose of this study was to determine predictors of LAE in children with HCM. METHODS: A retrospective data collection was performed on 446 children and teenagers 20 years and younger (290 [65%] male; mean age 10.1 ± 5.7 years) with idiopathic HCM from 35 centers. Patients were classified as group 1 (HCM with LAE) if having a secondary prevention implantable cardioverter-defibrillator (ICD) or primary prevention ICD with appropriate interventions or group 2 (HCM without LAE) if having a primary prevention ICD without appropriate interventions. RESULTS: There were 152 children (34%) in group 1 and 294 (66%) in group 2. Risk factors for group 1 by univariate analysis were septal thickness, posterior left ventricular (LV) wall thickness, lower LV outflow gradient, and Q wave > 3 mm in inferior electrocardiographic leads. Factors not associated with LAE were family history of SCD, abnormal blood pressure response to exercise, and ventricular tachycardia on ambulatory electrocardiographic monitoring. Risk factors for SCD by multivariate analysis were age at ICD placement (hazard ratio [HR] 0.9; P = .0025), LV posterior wall thickness z score (HR 1.02; P < .005), and LV outflow gradient < 30 mm Hg (HR 2.0; P < .006). LV posterior wall thickness z score ≥ 5 was associated with LAE. CONCLUSION: Risk factors for LAE appear different in children compared to adults. Conventional adult risk factors were not significant in children. Further prospective studies are needed to improve risk stratification for LAE in children with HCM.

Advocate Hospital Chicago Illinois

C S Mott Children's Hospital Ann Arbor Michigan

Carolinas Health System Charlotte North Carolina

Children's Hospital of Los Angeles Los Angeles California

Children's Hospital of Michigan Detroit Michigan

Children's Hospital of Philadelphia Philadelphia Pennsylvania

Children's Hospital Omaha Nebraska

Cleveland Clinic Cleveland Ohio

Columbia University New York New York

German Heart Center Munich Germany

Hospital for Sick Kids Toronto Ontario Canada

Mercy Children's Hospital Kansas City Missouri

Montefiore Hospital New York New York

Motol University Prague Czech Republic

Nationwide Children's Hospital Columbus Ohio

Oregon Health and Science University Portland Oregon

Phoenix Children's Hospital Phoenix Arizona

Royal Children's Hospital Glasgow Scotland United Kingdom

Royal Children's Hospital Melbourne Australia

Saint Louis University Saint Louis Missouri

Sibley Heart Center Atlanta Georgia

University of Alberta Edmonton Alberta Canada

University of British Columbia Vancouver British Columbia Canada

University of California Irvine Irvine California

University of California Los Angeles Los Angeles California

University of California San Francisco San Francisco California

University of Cologne Cologne Germany

University of Colorado Denver Colorado

University of Iowa Iowa City Iowa

University of Montreal Montreal Quebec Canada

University of Texas Southwestern Dallas Texas

University of Utah Salt Lake City Utah

University of Virginia Charlottesville Virginia

Vanderbilt University Nashville Tennessee

Zucker School of Medicine at Hofstra Northwell Hempstead New York

Citace poskytuje Crossref.org

Nejnovějších 20 citací...

Zobrazit více v
Medvik | PubMed

Patterns of Electrocardiographic Abnormalities in Children with Hypertrophic Cardiomyopathy

. 2024 Dec ; 45 (8) : 1692-1701. [epub] 20230909

Implantable cardioverter defibrillators in paediatric patients: yet another example of healthcare divergence?

. 2024 Aug 30 ; 26 (9) : .

Analysis of risk stratification and prevention of sudden death in pediatric patients with hypertrophic cardiomyopathy: Dilemmas and clarity

. 2023 Aug ; 4 (8) : 506-516. [epub] 20230620

2021 PACES Expert Consensus Statement on the Indications and Management of Cardiovascular Implantable Electronic Devices in Pediatric Patients: Executive Summary

. 2022 May-Jun ; 15 (3) : 323-346. [epub] 20221116

Relationship Between Maximal Left Ventricular Wall Thickness and Sudden Cardiac Death in Childhood Onset Hypertrophic Cardiomyopathy

. 2022 May ; 15 (5) : e010075. [epub] 20220502

2021 PACES expert consensus statement on the indications and management of cardiovascular implantable electronic devices in pediatric patients: Executive summary

. 2021 Nov-Dec ; 21 (6) : 349-366. [epub] 20210729

2021 PACES expert consensus statement on the indications and management of cardiovascular implantable electronic devices in pediatric patients

. 2021 Nov-Dec ; 21 (6) : 367-393. [epub] 20210729

Development of a Novel Risk Prediction Model for Sudden Cardiac Death in Childhood Hypertrophic Cardiomyopathy (HCM Risk-Kids)

. 2019 Sep 01 ; 4 (9) : 918-927.

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...